Research and Development Pipeline
We are a biopharmaceutical company dedicated to the development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious diseases. Our strategy is to build a diversified biopharmaceutical business focused in hematology and oncology based on a portfolio of commercial products and a development pipeline of novel drug candidates.
Our clinical development priorities are focused on sapacitabine in the following indications:
Acute myeloid leukemia, or AML, in the elderly; Myelodysplastic syndromes, or MDS; and Non-small cell lung cancer, or NSCLC. In January 11, 2011, the Company opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed AML who are not candidates for intensive induction chemotherapy. SEAMLESS is a registration-directed clinical trial and is conducted under a Special Protocol Assessment, or SPA, agreement with the U.S. Food and Drug Administration, or FDA. SEAMLESS is a randomized study against an active control drug with the primary objective of demonstrating an improvement in overall survival. After reviewing data from a pilot study of the active arm of the study, the SEAMLESS Data Safety Monitoring Board, or DSMB, recommended that the trial continue as planned.
The Company has advanced two additional product candidates, seliciclib in Phase 2 for NSCLC and nasopharyngeal cancer or NPC, and CYC116 in Phase 1 clinical development. The combination of sapacitabine with seliciclib is also being evaluated in a Phase 1 clinical trial. The Company will determine the feasibility of pursuing further development and/or partnering these assets depending on the availability of funding and further clinical data.
Read more about this topic: Cyclacel
Famous quotes containing the words research and, research, development and/or pipeline:
“To be sure, nothing is more important to the integrity of the universities ... than a rigorously enforced divorce from war- oriented research and all connected enterprises.”
—Hannah Arendt (1906–1975)
“If politics is the art of the possible, research is surely the art of the soluble. Both are immensely practical-minded affairs.”
—Peter B. Medawar (1915–1987)
“The highest form of development is to govern one’s self.”
—Zerelda G. Wallace (1817–1901)
“Even in the pink crib
the somehow deficient,
the somehow maimed,
are thought to have
a special pipeline to the mystical....”
—Anne Sexton (1928–1974)